Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...

When it comes to HIV prevention, the U.S. Supreme Court appeared to back up the task force with its July 11 ruling in Kennedy ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

The body that regulates charities in Britain issued a stern reprimand to a charity set up by Prince Harry over failings that ...

His study showed that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of life ultimately suppress the HIV viral reservoir to negligible levels. The ...

Large numbers of vulnerable HIV patients in South Africa are feared to have dropped off medication, in what campaigners warn ...

A London-wide HIV charity has said it could be forced to close if the funding crisis it is facing continues. Positively UK, ...

UConn Health Disparities Institute share their insights about the national Black Women First Initiative and the path forward ...

Unfinished Business' is a powerful documentary that revisits the lives of older African American women living with HIV, ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Analysts lift targets for Gilead as HIV sales surge and Yeztugo launch gains traction, supporting a stronger full-year ...